Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | -27,232 | N/A | -12,400 |
| Accounts receivable | -1,499 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,055 | N/A | -686 |
| Other Working Capital | 251 | N/A | -1,476 |
| Other Operating Activity | 8,367 | 0 | 1,245 |
| Operating Cash Flow | $-21,168 | $N/A | $-13,317 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -122,988 | N/A | -15,731 |
| PPE Investments | N/A | N/A | -19 |
| Sale Of Investment | 21,689 | N/A | N/A |
| Investing Cash Flow | $-101,299 | $N/A | $-15,750 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 269,113 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 8,423 |
| Financing Cash Flow | $269,113 | $N/A | $8,423 |
| Beginning Cash Position | 21,766 | N/A | 53,084 |
| End Cash Position | 168,412 | N/A | 32,440 |
| Net Cash Flow | $146,646 | $N/A | $-20,644 |
| Free Cash Flow | |||
| Operating Cash Flow | -21,168 | N/A | -13,317 |
| Capital Expenditure | N/A | N/A | -19 |
| Free Cash Flow | -21,168 | 0 | -13,336 |